Weight Loss
US$ 25.94
semaglutide and trevogrumab Combinations Show Promise in Phase 2 COURAGE Obesity Trial Preserve Muscle During Weight Loss?
Description
Torley D, Bellus GA, Munro CS
MICA risk consultants have talked with Utah and Arizona primary care practices considering prescribing compounded semaglutide for patients
The primary concern relates to potential teratogenic effects and the lack of adequate safety data in pregnant women
Much remains to be examined, and studies will need to be performed in the coming years for definitive answers
Key difference from GLP-1s: Doesn't suppress appetite
This guide compares the top providers to help you make an informed decision about which program aligns with your weight loss goals and budget
